There have been multiple reports associating mutations in the gene encoding the aCDase with spinal muscular atrophy with progressive myoclonic epilepsy (SMA-PME) [178–181], although initially the interest of aCDase was on its involvement in the lysosomal storage disease Farber's disease [182]. Here, ASAH1 is linked to progressive myoclonus epilepsy.